MEDICAL CHEMICAL DEFENSE (OP SYS DEV)
Abstract
This project provides for the upgrade and modernization of fielded medical nerve agent treatment system that contribute to the layered medical defenses against chemical warfare agent threats facing U.S. Forces in the field. The effort included in this project is: (1) Improved Never Agent Treatment System (INATS) INATS, which includes Food and Drug Administration (FDA) approved prophylactics, pre-treatments, and therapeutics, is intended to protect and/or sustain the Joint Service Member in a toxic chemical threat environment. Efforts and studies conducted under this project address direction from the FDA to conduct specific post-New Drug Application (NDA)-approval efforts and studies (e.g. required studies, Post Marketing Commitments), and requirements from the joint service users for the FDA-approved Soman Nerve Agent Pretreatment Pyridostigmine (SNAPP) product.
Document Details
- Document Type
- Project
- Publication Date
- Oct 01, 2020
- Source ID
- MC7_0607384BP_7_0400_PB_2020
Related Documents
- Root: CHEMICAL/BIOLOGICAL DEFENSE (OP SYS DEV)
- Child Accomplishment: 1) INATS
- Child Cost Item: 469933d0a7284cec1546a17a8df462b8